Panacea Global Inc. | |
Stock Exchange | Other OTC |
EPS |
- |
Market Cap |
$29.63 M |
Shares Outstanding |
106.75 M |
Public Float |
44 M |
Address |
330 Highway 7 East Richmond Hill Ontario L4B 3P8 Canada |
Employees | - |
Website | - |
Updated | 09/14/2018 |
Panacea Global, Inc. is a biotechnology company focused on the discovering, developing and commercializing of diagnostic products for the management of cancer. The company provides blood, serum and tissue tests to diagnose and monitor cancer through a licensing agreement with Panacea Pharmaceuticals. Its current product line allows for accurate detection of the most common forms of cancer, which includes diagnostic tests for lung, breast, prostate and colon cancers. |